Massachusetts General Hospital: Sclerosis trials

The registry lists 11 Sclerosis studies with Massachusetts General Hospital as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 1Phase 2 4Phase 3 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03168711Phase 2Results posted
• Light Therapy as Treatment for Fatigue in Multiple SclerosisCompletedNCT03060759Not applicableResults posted
• A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02288091Phase 1Results posted
• Gilenya in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01786174Phase 2Results posted
• Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00818389Phase 2/3Results posted
• Clinical Trial Ceftriaxone in Subjects With ALSCompletedNCT00349622Phase 3Results posted
• Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple SclerosisWithdrawnNCT04880577Phase 2
• Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple SclerosisCompletedNCT04130256Not applicable
• Imaging and BioFluid Biomarkers in Amyotrophic Lateral SclerosisCompletedNCT02559869
• A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) BiomarkersCompletedNCT01495390
• Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00677768